Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CDK1 | P06493 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9197645 | 0.93 | CDK1 (0.55) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL27544563 | 0.86 | CDK1 (0.38) | GAACDK1TP53KMT2AMEN1 | |
| SCHEMBL9202913 | 0.85 | CDK1 (0.55) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL8106622 | 0.83 | GAA (0.58) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL1405765 | 0.82 | GAA (0.59) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL9724731 | 0.80 | GAA (0.55) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL9724767 | 0.79 | GAA (0.54) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL27455262 | 0.79 | CDK1 (0.41) | GAACDK1TP53KMT2AMEN1 | |
| SCHEMBL9080269 | 0.79 | CDK1 (0.62) | GAACDK1CYP1A2TP53GLA | |
| SCHEMBL11100011 | 0.78 | GAA (0.55) | GAACDK1CYP1A2TP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994006778-A1 | HYDROXYL AMINO PHENYL SULPHONYL UREAS, THEIR PREPARATION AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | HOECHST SCHERING AGREVO GMBH (DE) | 1994-03-31 | — | — | WO | disclosed |